), GlaxoSmithKline has received 1,115 “underperform” votes. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Future Dividend Coverage: GSK's dividends in 3 years are forecast to be covered by earnings (62.1% payout ratio). GSK’s share price has fallen by nearly 25% so far this year. (Add your “underperform” vote.). A Warner Media Company. Shares of GSK can be purchased through any online brokerage account. Ralph Lauren (NYSE: RL) Has Room To Run Another 30%, 3 Grocery Store Stocks to Put in Your Cart, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, Receive Analysts' Upgrades and Downgrades Daily. Glaxosmithkline Plc's stock had its IPO on July 9, 1986, making it an older stock than 92.32% of US equities in our set. The dividend payout ratio of GlaxoSmithKline is 64.35%. Next Steps Explore strong dividend paying … Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. GlaxoSmithKline pays an annual dividend of $2.04 per share and currently has a dividend yield of 5.30%. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. To see all exchange delays and terms of use please see disclaimer. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Glaxosmithkline stock was originally listed at a price of $47.88 in Dec 31, 1997. Get daily stock ideas top-performing Wall Street analysts. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. View insider buying and selling activity for GlaxoSmithKline or view top insider-selling stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. 323,181 shares of the stock traded hands, compared to its average volume of 4,043,910. MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. With a 5-year investment, the revenue is expected to be around +34.32%. All rights reserved. GlaxoSmithKline's management team includes the following people: Biden’s New Plan – What No One is Telling You. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. I think this is too cheap. Some companies that are related to GlaxoSmithKline include Roche (RHHBY), Novartis (NVS), Merck & Co., Inc. (MRK), Pfizer (PFE), Abbott Laboratories (ABT), AbbVie (ABBV), Eli Lilly and (LLY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb (BMY), AstraZeneca (AZN), Sanofi (SNY), CSL (CSLLY), Zoetis (ZTS), Vertex Pharmaceuticals (VRTX) and Bayer Aktiengesellschaft (BAYRY). The price has been going up and down for this period, and there has been a 1.89% gain for the last 2 weeks. The ex-dividend date of this dividend is Thursday, November 12th. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, GSK stock has decreased by 3.3% and is now trading at $38.54. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend … GlaxoSmithKline PLC ADR analyst ratings, historical stock prices, earnings estimates & actuals. GlaxoSmithKline has a market capitalization of $96.68 billion and generates $43.10 billion in revenue each year. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. GlaxoSmithKline has a PEG Ratio of 2.93. GSK updated stock price target summary. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. A rank of 34 means that 66% of stocks appear more favorable to our system. With a 5-year investment, the revenue is expected to be around +8.55%. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. Given the current horizontal trend, you can expect GlaxoSmithKline PLC stock with a 90% probability to be traded between $33.98 and $39.74 at the end of this 3-month period. GlaxoSmithKline is a leading dividend payer. GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and … Price Target Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. What this means: InvestorsObserver gives Glaxosmithkline Plc (GSK) an overall rank of 34, which is below average. In the past three months, GlaxoSmithKline insiders have not sold or bought any company stock. Jan 15 / Zacks.com - Paid Partner Content, Jan 12 / MotleyFool.com - Paid Partner Content, Jan 14 / MotleyFool.com - Paid Partner Content, Jan 12 / Zacks.com - Paid Partner Content, Jan 13 / Zacks.com - Paid Partner Content, Jan 08 / Zacks.com - Paid Partner Content, Jan 07 / Zacks.com - Paid Partner Content, Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals, Why Vir Biotechnology Stock Vaulted Higher Today, Gilead (GILD) Ups Revenue Guidance on Increased Veklury Demand, Merck (MRK) Gets Priority Tag for Pneumococcal Vaccine BLA, The Zacks Analyst Blog Highlights: UnitedHealth Group, Netflix, Caterpillar, General Electric and GlaxoSmithKline, Vir Biotech, Glaxo to Begin Study on Second COVID-19 Therapy, Top Stock Reports for UnitedHealth, Netflix & Caterpillar, This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. Glaxosmithkline plc - ADR (GSK) stock price prediction is 70.847354 USD. The Company operates through two segments: Pharmaceuticals and Vaccines. GlaxoSmithKline has only been increasing its dividend for 1 years. This is a boost from GlaxoSmithKline's previous quarterly dividend of $0.49. The Company makes a range of prescription medicines and vaccines … GSK Stock Trend. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Identify stocks that meet your criteria using seven unique stock screeners. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. Dip below 35.99 ~ 35.70 range Twice , back up to 36.30 <---- 50+ cent gap ups. You may vote once every thirty days. Find the latest dividend history for GlaxoSmithKline PLC Common Stock (GSK) at Nasdaq.com. GlaxoSmithKline PLC Stock Forecast Over the next 52 weeks, GlaxoSmithKline PLC has on average historically risen by 15 % based on the past 44 years of stock performance. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Only 11.83% of the stock of GlaxoSmithKline is held by institutions. 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. View GlaxoSmithKline's dividend history. PEG Ratios above 1 indicate that a company could be overvalued. GlaxoSmithKline PLC has risen higher in 26 of those 44 years over the subsequent 52 week period, corresponding to a historical probability of 59 % This suggests a possible upside of … It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. That leaves the stock trading on just 12 times forecast earnings, with a dividend yield of 5.8%. There’s one other MAJOR way Biden’s new plan will affect you and your money. GlaxoSmithKline employs 99,437 workers across the globe. The Glaxosmithkline plc - ADR stock forecast is 70.847354 USD for 2022 January 16, Sunday; and 267.671 USD for 2026 January 16, Friday with technical analysis. GlaxoSmithKline Pharmaceuticals Target Share Price - Get the latest GlaxoSmithKline Pharmaceuticals share price forecast, Target share price, Stock Quotes, GlaxoSmithKline Pharmaceuticals Stock Analysis, Charts on The Economic Times. Fortunes will be made and lost in 2021 – and you likely have just weeks to decide which side you’ll be on. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis. GlaxoSmithKline's stock is owned by many different institutional and retail investors. Vote “Underperform” if you believe GSK will underperform the S&P 500 over the long term. 19 brokers have issued 1 year price objectives for GlaxoSmithKline plc (GSK.L)'s shares. GlaxoSmithKline PLC (GSK:LSE) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency v irus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. Is the Beyond Meat (NASDAQ: BYND) Rally Sustainable? GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. This price target is based on 12 analysts offering 12 month price targets for GlaxoSmithKline in the last 3 months. All times are ET. View all of GSK's competitors. The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. GlaxoSmithKline does not yet have a strock track record of dividend growth. GlaxoSmithKline has a P/B Ratio of 4.10. Learn more. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. However, solely looking at the historical price movement is usually misleading. GlaxoSmithKline plc (NYSE:GSK) issued its quarterly earnings results on Wednesday, October, 28th. The GlaxoSmithKline PLC stock price gained 0.59% on the last trading day (Wednesday, 13th Jan 2021), rising from $37.46 to $37.68. You can opt out at any time. Disclaimer. Receive a free world-class investing education from MarketBeat. I dont see much Downside as Compared to upside. View which stocks are hot on social media with MarketBeat's trending stocks report. Wall Street analysts have given GlaxoSmithKline a "Hold" rating, but there may be better short-term opportunities in the market. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. The pharmaceutical company reported $0.92 EPS for the quarter, topping the Zacks' consensus estimate of $0.78 by $0.14. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Your current $100 investment may be up to $108.55 in 2026. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. This payout ratio is at a healthy, sustainable level, below 75%. Do Not Sell My Information. This payout ratio is at a healthy, sustainable level, below 75%. © American Consumer News, LLC dba MarketBeat® 2010-2021. View institutional ownership trends for GlaxoSmithKline. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Factset: FactSet Research Systems Inc.2019. Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-23 is 39.945 USD. Your current $100 investment may be up to $134.32 in 2026. GlaxoSmithKline has received 764 “outperform” votes. If you had invested in Glaxosmithkline stock at $47.88, your return over the last 23 years would have been -19.92%, for an annualized return of -0.96%. Their forecasts range from GBX 1,300 to GBX 2,240. During the day the stock fluctuated 0.76% from a day low at $37.56 to a day high of $37.84. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. What this means: InvestorsObserver gives Glaxosmithkline Plc (GSK) an overall rank of 33, which is below average. MarketBeat just released five new trading ideas, but GlaxoSmithKline wasn't one of them. The firm has a market capitalization of $96.65 billion, a price-to-earnings ratio of 11.82, a price-to-earnings-growth ratio of 2.93 and a beta of 0.67. View analyst ratings for GlaxoSmithKline or view MarketBeat's top 5 stock picks. Is GlaxoSmithKline a buy right now? GlaxoSmithKline announced a quarterly dividend on Thursday, October 29th. Fundamental company data provided by Morningstar and Zacks Investment Research. GSK Stock is A bit Undervalued RIght now.. Institutions have price targets of 42~-48 back on the Covid-low-trendline .. GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK.". Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), The Walt Disney (DIS) and NVIDIA (NVDA). Climbing the patent cliff. Glaxosmithkline's earnings in 2019 is $6,111,842,105.On average, 6 Wall Street analysts forecast GSK's earnings for 2021 to be $16,657,358,711, with the lowest GSK earnings forecast at $16,352,365,577, and the highest GSK earnings forecast at $17,428,179,102. GSK stock was acquired by a variety of institutional investors in the last quarter, including Galibier Capital Management Ltd., Douglas Lane & Associates LLC, Gilman Hill Asset Management LLC, Jacobs & Co. CA, SevenBridge Financial Group LLC, Bonness Enterprises Inc., Signature Wealth Management Group, and Crescent Capital Consulting LLC. The P/E ratio of GlaxoSmithKline is 11.86, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 35.43. According to 6 analysts, the average rating for GSK stock is "Buy." There is not enough analysis data for GlaxoSmithKline. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. The Next Few Weeks Could Decide Your Wealth in ‘21. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Sign-up to receive the latest news and ratings for GSK and its competitors with MarketBeat's FREE daily newsletter. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. View GlaxoSmithKline's dividend history. GlaxoSmithKline has received 59.34% “underperform” votes from our community. Earnings for GlaxoSmithKline are expected to grow by 0.33% in the coming year, from $3.07 to $3.08 per share. The pharmaceutical company earned $11.17 billion during the quarter, compared to analyst estimates of $11.27 billion. GSK Stock Summary. All Rights Reserved. Investors of record on Friday, November 13th will be paid a dividend of $0.4959 per share on Thursday, January 14th. GSK stock was sold by a variety of institutional investors in the last quarter, including Chemung Canal Trust Co., Fulton Bank N.A., City Holding Co., Raymond James Trust N.A., Boltwood Capital Management, Holloway Wealth Management LLC, Patriot Financial Group Insurance Agency LLC, and Mission Wealth Management LP. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. Since then, GSK stock has decreased by 7.2% and is now trading at $36.98. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Export data to Excel for your own analysis. Learn everything you need to know about successful options trading with this three-part video course. View insider buying and selling activity for GlaxoSmithKline or or view top insider-buying stocks. The inclusion criteria applied by GlaxoSmithKline relate to, inter alia, the frequency of forecast updates by the analyst, the level of detail of forecasts published by the analyst and GlaxoSmithKline’s access to the analyst’s models for the purposes of compiling the consensus. See GlaxoSmithKline PLC (GSK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. On average, they expect GlaxoSmithKline plc (GSK.L)'s stock price to reach GBX 1,763 in the next twelve months. Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-23 is 1802.630 GBX. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021. Vote “Outperform” if you believe GSK will outperform the S&P 500 over the long term. Get Our PREMIUM Forecast Now, from ONLY $6.69! GSK Stock Analysis Overview . Looking for new stock ideas? Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. All rights reserved. The average price target represents a -100.00% upside from the last price of $36.80. Get Our PREMIUM Forecast Now, from ONLY $6.69! View our full suite of financial calendars and market data tables, all for free. View GlaxoSmithKline's earnings history. Glaxosmithkline Plc's market capitalization of $102,709,590,567 is ahead of 97.8% of US-listed equities. With Covid vaccine News coming any day now - … We don’t hear much about the patent cliff anymore, but it’s still a real … Want to see which stocks are moving? The official website for GlaxoSmithKline is www.gsk.com. Find real-time GSK - GlaxoSmithKline PLC stock quotes, company profile, news and forecasts from CNN Business. GlaxoSmithKline PLC is a global healthcare company. GlaxoSmithKline PLC is estimated to report earnings on 02/03/2021. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. Learn about financial terms, types of investments, trading strategies and more. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Only 10.00% of the stock of GlaxoSmithKline is held by insiders. GlaxoSmithKline's mailing address is 980 GREAT WEST ROAD, BRENTFORD X0, TW8 9GS. View which stocks have been most impacted by COVID-19. The 12-month stock price forecast is 48.50, which is an increase of 26.07% from the latest price. There are currently 2 sell ratings, 5 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GlaxoSmithKline stock. Most stock quote data provided by BATS. This represents a $1.98 dividend on an annualized basis and a yield of 5.15%. NYSE:GSK traded up $0.06 on Friday, reaching $38.53. (Add your “outperform” vote. 150,004 shares of the stock were exchanged, compared to its average … The P/E ratio of GlaxoSmithKline is 11.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.54. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. Learn more. GlaxoSmithKline had a net margin of 18.50% and a return on equity of 29.60%. © 2020 Cable News Network. One share of GSK stock can currently be purchased for approximately $38.54. CNN Sans™ & © 2016 Cable News Network. Get short term trading ideas from the MarketBeat Idea Engine. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. View our earnings forecast for GlaxoSmithKline. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. GLAXOSMITHKLINE PLC : Forcasts, revenue, earnings, analysts expectations, ratios for GLAXOSMITHKLINE PLC Stock | GSK | GB0009252882 GLAXOSMITHKLINE PLC earnings per share revisions and analysts forecast | London Stock Exchange: GSK | London Stock Exchange Chief Scientific Officer, Pres of R&D and Director, Sr. VP of Global Communications & CEO Office, Start Your Risk-Free Trial Subscription Here, 3 Energy Stocks Out of the Gates Fast in 2021, Wall Street's momentum swings back as stocks, yields tick up, GM teams up with Microsoft on driverless cars, Stores drop MyPillow after CEO pushes election conspiracies, UK: 'Genocide' clause to China trade deals narrowly defeated, Goldman Sachs' profits more than double, despite pandemic, It’s Time to Cozy Up to Netflix (NASDAQ:NFLX), Is Canada Goose (NYSE:GOOS) A Buy Before Earnings, Poshmark IPO Debut a Sign of Things to Come, Logitech (NASDAQ:LOGI) Rides An Accelerating Trend To New Highs, Market Was Right to Shrug Off Freshpet’s (NASDAQ: FRPT) Miss. View which stocks have been most impacted by COVID-19. The pharmaceutical company can be reached via phone at 44-20-8047-5000 or via email at [email protected]. Please log in to your account or sign up in order to add this asset to your watchlist. However, solely looking at the historical price movement is usually misleading. It pays a dividend yield of 5.30%, putting its dividend yield in the top 25% of dividend-paying stocks. Top institutional investors include Douglas Lane & Associates LLC (0.05%), Galibier Capital Management Ltd. (0.02%), Jacobs & Co. CA (0.01%), Holloway Wealth Management LLC (0.00%), Signature Wealth Management Group (0.00%) and Old Port Advisors (0.00%). GSK stock traded up $0.12 during mid-day trading on Tuesday, hitting $38.59. See what's happening in the market right now with MarketBeat's real-time news feed. gsk $38.47 $0.31 0.8% Price as of January 15, 2021, 9:00 p.m. EST View Interactive GSK Charts The dividend payout ratio of GlaxoSmithKline is 64.35%. All rights reserved. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Bl3 Dedicated Drops Spreadsheet 2020, G Z Up, Hoes Down, Bge Customer Service Hours, Synonyms For Torn Between Two Things, Cavachon Puppies For Adoption, Portland Police Officer Hastings Jamie, Ful Gobhi In English, Toyota 4runner Jbl Subwoofer Replacement, Johns Hopkins Pediatric Residency, Paul Simon Now, Department Of Health Kzn Tenders,